Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 571 AL 585

GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease

Hölscher C.

Front Neurosci. 2026 Aug 14;20:1906426. doi: 10.3389/fnins.2026.1906426. eCollection 2026.

Sex Differences in Levodopa-Sparing Effect of Safinamide: Post-hoc Findings from a Multicenter, Longitudinal, Case-Control Study

Cilia R, Cereda E, Colucci F, Piatti M, Bonvegna S, Pilotto A, Comi C, Mancini F, Zibetti M, De Micco R, Sensi MC, Ceravolo R, Zangaglia R, Di Fonzo A, Pellecchia MT, Modugno N, Sorbera C, Canesi M, Pistoia F, Eleopra R.

Mov Disord Clin Pract. 2026 Sep;13(9):2210-2215. doi: 10.1002/mdc3.70642. Epub 2026 Apr 21.

Plasma neurofilament light for early differentiation of multiple system atrophy from Parkinson disease

Yu Z, Zheng Y, Kou W, Cai H, Li S, Wu J, Yang C, Zhu B, Liu G, Wang Y, Tian H, Zhang X, Zhou Y, Liu X, Chang Y, Chen Z, Mao W, Feng T.

EBioMedicine. 2026 Sep;131:106461. doi: 10.1016/j.ebiom.2026.106461. Epub 2026 Aug 31.

Effects of basic and dual-task training programs on physical function in Parkinson's disease: The PARKEX study

Magaña JC, Enríquez-Calzada S, Prat R, Deus CM, Pereira SP, Avellanet M, Gea E, Laguna A, Martinez-Vicente M, Perez-Larumbe O, Giné-Garriga M, Hernández-Vara J, Montane J.

PLoS One. 2026 Sep 18;21(9):e0358534. doi: 10.1371/journal.pone.0358534. eCollection 2026.

Cannabis and Cannabinoids: The Medical Potential of Cannabidiol in Mental and Neurological Disorders

Șolea R, Șerban E, Călugăr-Solea SF, Mathe E, Blebea NM, Hancu G, Serban G.

Pharmaceuticals (Basel). 2026 Aug 6;19(8):1238. doi: 10.3390/ph19081238.

Not always the usual suspect: symptom variations in Parkinson's disease beyond ON-OFF fluctuations

Ebersbach G, Jost WH, Koschel J, Müller R, Paus S, Urban PP, Poewe W, Storch A.

J Neural Transm (Vienna). 2026 Aug 27. doi: 10.1007/s00702-026-03266-1. Online ahead of print.

The olfactory-glymphatic syndrome: linking smell dysfunction, cognitive impairment and sleep disturbances in neuropathological disorders

Phillips WT, Schwartz JG.

Front Neurosci. 2026 Aug 12;20:1897376. doi: 10.3389/fnins.2026.1897376. eCollection 2026.

Parietal Cortex Transcriptomics Refines Parkinson Disease GWAS Nomination and Highlights STAT3 as a Putative Upstream Glial Regulator

Alfradique-Dunham I, Sanford J, Liu M, Perrin RJ, Franklin EE, Norris S, Kotzbauer PT, Perlmutter JS, Budde JP, Cruchaga C, Ibanez L, Minaya M.

bioRxiv [Preprint]. 2026 Aug 18:2026.08.13.744719. doi: 10.64898/2026.08.13.744719.

Chronic Paraquat Neurotoxicity and Dopaminergic Degeneration: A Mechanistic Review

Riaz S, Ali S, Summer M, Iqbal A, Ashraf R, Bibi R.

Chem Biodivers. 2026 Sep;23(9):e71676. doi: 10.1002/cbdv.71676.

Rebalancing α-Synuclein Clearance: Novel Therapeutic Frontiers in Parkinson's Disease

Jabeen M, Hameed H, Ahmad SM, Mushtaq T, Khan MA, Hameed A.

Neuromolecular Med. 2026 Aug 31;28(1):51. doi: 10.1007/s12017-026-08948-3.

Nanotechnology-enabled delivery of bioactive compounds for neuroprotection in Parkinson's disease: mechanisms and future directions

Gaur P, Bisht PR, Lal Gupta S.

J Biomater Sci Polym Ed. 2026 Aug 29:1-31. doi: 10.1080/09205063.2026.2723464. Online ahead of print.

Psychosocial determinants of exercise behavior in Parkinson's disease: a mini-review

Zhang G.

Front Public Health. 2026 Sep 3;14:1942675. doi: 10.3389/fpubh.2026.1942675. eCollection 2026.

Efficacy and safety of extended-release carbidopa-levodopa (IPX203) versus immediate-release carbidopa-levodopa for Parkinson's disease: A systematic review

Attar A, Aljadani HH, Barwais KF, Alqsair AA, Alharbi FA, Alharith HM, Fallatah AA, Halabi MH, Hakami AY, Zagzoog N.

J Int Med Res. 2026 Sep;54(9):3000605261477638. doi: 10.1177/03000605261477638. Epub 2026 Sep 2.

The promise and challenges of focused ultrasound therapy in the management of Parkinson's disease

Paio F, Tinazzi M, Tamburin S.

Expert Rev Neurother. 2026 Sep 2:1-5. doi: 10.1080/14737175.2026.2725110. Online ahead of print.

Correction: Effects of Telehealth Interventions for People With Parkinson Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Sun M, Tang F, Min L, Wen S, Wang S, Jiang H.

JMIR Mhealth Uhealth. 2026 Sep 1;14:e108495. doi: 10.2196/108495.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias